The risk of both mortality and rehospitalization after an elective revascularization procedure for coronary artery disease is similar for people with and without Alzheimer’s disease (AD), but people with AD had worse outcomes after an emergency procedure, according to a new study from the University of Eastern Finland.
Previous studies have investigated the effectiveness of revascularization in persons with cognitive disorders, but only in terms of short-term outcomes and in acute care settings, and they also have not accounted for electivity. Similar to previous studies, people with Alzheimer’s disease were 76% less likely to undergo a revascularization procedure and only a third of the procedures were elective, compared to 48.6% of elective procedures in the comparison group without AD.Read:Researchers find new way to diagnose potential for Alzheimer’s disease method less invasive, costly
People with Alzheimer’s disease had a higher risk of mortality in the procedural unit, and a 1.42-fold mortality rate during a 3-year follow-up, compared to people without AD. However, the risks were similar for elective procedures in persons with and without AD. Sociodemographic characteristics, comorbidities, statin use, length of stay and required support at discharge were controlled for in the analyzes. The results were similar for both revascularization procedure types studied, i.e., coronary artery bypass graft surgery (CABG) and percutaneous coronary interventions (PCI).
These observations on a lower rate for elective revascularizations and comparable outcomes after revascularization procedures indicate a different threshold for elective procedures compared to emergency ones, and a very different selection for people with major cognitive disorders.
The study was conducted as part of the Medication Use and Alzheimer’s Disease Study (MEDALZ), in a cohort which includes 70,718 Finnish community dwellers with Alzheimer’s disease, and a matched comparison cohort. This study was restricted to people who had no previous revascularization.
The study was published in the Journals of Gerontology: Series A, and it was funded by the Schlumberger Foundation and the Academy of Finland.Read:SuperAger brains resist protein tangles that lead to Alzheimer’s
SLE Medicaid patients have higher 30-day death rate compared to those with diabetes
Coronary Revascularization and Postoperative Outcomes In People With And Without Alzheimer’s Disease. Journals of Gerontology: Series A, 2021 Jan 9. DOI: 10.1093/gerona/glab006
University of Eastern Finland Read:Protein linked to Alzheimer’s, strokes cleared from brain blood vessels
People with Alzheimer’s have worse outcomes after an emergency revascularization (2021, February 15)
retrieved 15 February 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.